KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Total Debt: 2009-2011

Historic Total Debt for Acadia Pharmaceuticals (ACAD) over the last 3 years, with Dec 2011 value amounting to $32,000.

  • Acadia Pharmaceuticals' Total Debt fell 50.00% to $22,000 in Q1 2012 from the same period last year, while for Mar 2012 it was $22,000, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $32,000 for FY2011, which is 58.97% down from last year.
  • Acadia Pharmaceuticals' Total Debt amounted to $32,000 in FY2011, which was down 58.97% from $78,000 recorded in FY2010.
  • Acadia Pharmaceuticals' Total Debt's 5-year high stood at $365,000 during FY2009, with a 5-year trough of $32,000 in FY2011.
  • Its 3-year average for Total Debt is $158,333, with a median of $78,000 in 2010.
  • Data for Acadia Pharmaceuticals' Total Debt shows a maximum YoY tumbled of 78.63% (in 2010) over the last 5 years.
  • Over the past 3 years, Acadia Pharmaceuticals' Total Debt (Yearly) stood at $365,000 in 2009, then crashed by 78.63% to $78,000 in 2010, then crashed by 58.97% to $32,000 in 2011.